Navigation Links
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Date:9/4/2007

PHILADELPHIA, Pa., Sept. 4 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced new results from a large study that demonstrate combination treatment with AVODART (dutasteride) and the alpha blocker tamsulosin provides significantly greater urinary symptom improvement for men with enlarged prostate than either AVODART or tamsulosin monotherapy over 24 months. Three analyses from the study - Combination therapy with Avodart and tamsulosin (CombAT) - were presented today at the 29th annual meeting of the Societe Internationale d'Urologie in Paris.

In addition, one of three analyses presented -- a post hoc analysis -- showed that AVODART provides a pattern of increasing enlarged prostate symptom improvement over 24 months. Tamsulosin -- the most commonly prescribed medicine for the condition -- provided early symptom improvement, but this improvement plateaued from month three through 24.1 Common symptoms of enlarged prostate include nocturia, frequency and urgency, incomplete emptying, starting and stopping, and weak stream.

The CombAT study includes 4,800 men (combination therapy, n=1492; AVODART, n=1502; tamsulosin, n=1519) with moderate-to-severe enlarged prostate symptoms. All study participants received placebo for four weeks and then were randomized to receive AVODART and tamsulosin combination therapy, AVODART monotherapy, or tamsulosin monotherapy.

Enlarged prostate (also known as benign prostatic hyperplasia (BPH)), is a condition that affects 50 percent of men over the age of 50 and more than 90 percent of men over age 80. AVODART belongs to a class of medicines known as 5 alpha reductase inhibitors (5 ARIs), which shrink the prostate over time. Tamsulosin is an alpha blocker,
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Ky., Nov. 6 Virtual He... confirmed today that the previously confirmed Let...ts to Wound Management Technologies, Inc (WNDM) is...ors and shareholders of VHGI. ,, Shareholder...stock dividend, royalty stream and cash realized f...
(Date:11/6/2009)... Nov. 6 Keryx Biopharmac...ence call on Tuesday, November 10, 2009 at 8:30 a.... results and business outlook for the remainder of...e Company, will host the call. Keryx will announc... release to be issued prior to the call. ,, In ...
(Date:11/6/2009)..., Nov. 6 NexBio Inc., in collabora...ntrol and Prevention (CDC), St. Louis University, ...he publication of two articles in the peer-reviewe...uggest that DAS181 (Fludase ® ) may play a po...vention of the Pandemic Influenza A(H1N1) and drug...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Life Beyond Cancer Womens Retreat Calls for Applications 48335 1Life Beyond Cancer Womens Retreat Calls for Applications 48335 2Life Beyond Cancer Womens Retreat Calls for Applications 48335 3New study indicates radiologists need standards to ensure optimal visual accuracy 48331 1Mars mission could ease Earths energy supply crisis 8768 1Mars mission could ease Earths energy supply crisis 8768 2
(Date:11/8/2009)... UCW Academy of Health holds open... Victoria, BC (Vocus) November 8, 2009 -- UCW Ac...career in British Columbia’s health care ind...dnesday, November 25, 2009. , ,UCW Academy of Hea...stration, nursing and social services, designs its...
(Date:11/8/2009)...gher Costs and Crushing Taxes Nail Nation,s Job Cr...wire/ -- In response to U.S. House passage of the ... Entrepreneurship Council (SBE Council) president ...ement: ,, "Make no mistake, those voting for H... with higher costs and crushing taxes and penaltie...
(Date:11/8/2009)...SHINGTON, Nov. 7 Tonigh...le Health Care for America Act, landmark health re...as access to quality, affordable, stable and secur...cks down on some of the insurance industry,s worst...ericans and cut the deficit by $104 billion over t...
(Date:11/8/2009)... 3D Global Solutions is pleased t...managing the proposal effort for ReSound who recen...al Hearing Aid contract. The award includes not on...tment of Defense and other federal agencies. , ...r 8, 2009 -- 3D Global Solutions is pleased to ann...
(Date:11/8/2009)... Men’s Health Network (MHN)...th risks, especially those linked to exposure to c...itary service. Bladder cancer is one of those canc...especially those who once smoked or currently smok...n DC (PRWEB) November 8, 2009 -- Men’s Healt...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3
...EWOOD, Colo., July 18 Baxa Corporation, a,Denver-...for preparing,handling, packaging, and administeri...esigned Web site for health-system users of its so...ng,with creating a virtual ,community, for sharing...
...YORK, July 18 Standing Tall announced today that,...nne Bernadette Peters has,joined its Board of Dire...rogram, unique in the area,that supports the most ...odies to learn to walk and talk as they also learn...
... The Health Insurance Advoca...ael Cannon to specify why Medicare is not the mode... Kansas City, MO (PRWEB) July 18, 2008 -... health policy studies at the Cato Institute, whol...
... Prestigious Healthcare Lead...inic Provider NextCare , ...linic NextCare ( www.nextcare.com ), the world...oard of Directors . Those joining the counsel incl...
...mark Atlas Holds Vast Potential to Accelerate Life... Research, Project Made Possible through Gener... to Advancing Breakthrough Spinal Cord Discoveries... map of the mouse spinal cord. Researchers can,imm...
...sport(sm) First Mobile Medical Service for Access ...re Anywhere, RADNOR, Pa., July 17 HTH Worldwide,...y introduced mPassport(sm), a mobile health,inform...n they are on the go and on their mobile phone. Su...
Other Medicine News:Health News:Baxa Corporation Launches New Electronic Users' Group Web Site 2Health News:Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children 2Health News:Medicare Fraud: How Many Dead Doctors Does it Take to Prescribe $90 Million in Medical Equipment for Medicare Patients? 2Health News:Medicare Fraud: How Many Dead Doctors Does it Take to Prescribe $90 Million in Medical Equipment for Medicare Patients? 3Health News:Medicare Fraud: How Many Dead Doctors Does it Take to Prescribe $90 Million in Medical Equipment for Medicare Patients? 4Health News:Urgent Care Provider NextCare Announces new Board of Directors 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 3Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 2Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 3
VISUCAMPRO NM
HDL Cholesterol, Direct Test
Pediatric ThermoWrap™
Bair Hugger® Model 537 - Small Lower Body Blanket
Medicine Products: